Physician profile
Frank Eugene Ferro
NPI 1104032093
$1,134.51
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $79.90 · 2021: $58.98 · 2022: $78.57 · 2023: $212 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $214.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $128.91 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Pfizer INC. | $123.19 | 2019-2023 | |
| Amgen INC. | $110.58 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.97 | 2020-2024 | Lifevest |
| Insmed, INC. | $80.08 | 2019 | |
| Abbott Laboratories | $72.40 | 2023-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $56.00 | 2023 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $45.81 | 2019-2021 | |
| Angiodynamics, INC. | $31.72 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $24.77 | 2023 | Inpefa |
| Terumo Cardiovascular Systems Corporation | $16.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Ferro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.